Skip to main content

Year: 2021

Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of October 31, 2021

Declaration of the number of outstanding shares and voting rights as of October 31, 2021 Vélizy-Villacoublay (France) November 8, 2021 – Dassault Systèmes (Euronext Paris: #14003TT8, DSY.PA) reports below the total number of its outstanding shares and voting rights as of October 31, 2021, according to articles 223-16 and 221-3 of the General Regulation of the Autorité des marchés financiers. Number of outstanding shares: 1,331,886,457          Number of voting rights*: 1,992,515,631 *The total number of voting rights is calculated on the basis of the total number of outstanding shares, even if the voting rights attached thereto are suspended, pursuant to Article 223-11 of the General Regulation of the Autorité des marchés financiers relating to the method for calculating the percentages of holdings in shares and in voting rights. We invite...

Continue reading

Global Diabetes Drugs Market to Reach USD 78,261.7 Million by 2026 | Market Size, Share, Growth, Revenue, Forecasts, & Trends Analysis Report with COVID-19 Impact by Fortune Business Insights™

Key companies in Global Diabetes Drugs Market are Novo Nordisk A/S, Sanofi, Merck & Co., Inc., Eli Lilly and Company, AstraZeneca, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Novartis AG, Johnson & Johnson Services, Inc., and Bayer AG. Pune, India, Nov. 08, 2021 (GLOBE NEWSWIRE) — The Global “Diabetes Drugs Market” derives growth from advancements in drug delivery systems. According to a report published by Fortune Business Insights, titled “Diabetes Drugs: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 48,753.1 Mn in 2018. Fortune Business Insights has predicted that the market will be valued at US$ 78,261.7 Mn by the end of 2026, thereby exhibiting a CAGR of 6.1%. Key Players:Novo Nordisk A/S, Sanofi Merck & Co., Inc. Eli Lilly and...

Continue reading

Ambarella Closes Acquisition of Oculii

SANTA CLARA, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) — Ambarella, Inc. (NASDAQ: AMBA), an AI vision silicon company, today announced the completion of its previously announced transaction to acquire Oculii Corp. On October 26, 2021, Ambarella announced that Oculii and Ambarella had signed a definitive merger agreement, pursuant to which Ambarella would acquire all outstanding capital stock of Oculii for $307.5 million. On November 5, 2021, pursuant to the terms of the merger agreement, Ohio Merger Sub, Inc. merged with and into Oculii, and all outstanding capital stock of Oculii was cancelled and converted into the right to receive cash. As a result of the merger’s completion, Oculii has become a wholly owned subsidiary of Ambarella. Oculii co-founder and CEO, Steven Hong, will serve as Ambarella’s Vice President and General Manager,...

Continue reading

Healthcare Analytics Market Size is Projected to Reach USD 80.21 Billion by 2026 | Market Size, Share, Growth, Revenue, Forecasts, & Trends Analysis Report with COVID-19 Impact by Fortune Business Insights™

Healthcare Analytics Market Key Players Studied In this Report are Cerner Corporation, IBM Corporation (IBM Watson), Flatiron Health, Linguamatics, Allscripts Healthcare, LLC, Epic Systems Corporation, Health Catalyst, Inovalon Pune, India, Nov. 08, 2021 (GLOBE NEWSWIRE) — According to the report, Healthcare Analytics market size is projected reach USD 80.21 billion by 2026. Healthcare analytics market was valued at USD 11.59 billion in 2018. The advancement in technologies along with growing venture capital funding will aid the market in the region. The global healthcare analytics market size is predicted to reach USD 80.21 billion by 2026, exhibiting a CAGR of 27.5% during the forecast period. The emergence of big data in healthcare can be a vital factor in boosting the healthcare analytics market revenue during the forecast...

Continue reading

Heat Exchanger Market worth USD 33.57 billion by 2030, registering a CAGR of 8.35% – Report by Market Research Future (MRFR)

New York, Nov. 08, 2021 (GLOBE NEWSWIRE) — Heat Exchanger Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “Heat Exchanger Market Research Report, Type, Application and Region – Forecast till 2027” the market is projected to be worth USD 33.57 billion by 2030, registering a CAGR of 8.35% during the forecast period (2022 – 2030), The market was valued at USD 17.84 billion in 2021. List of the companies profiled in the global heat exchanger industry report includeAlfa Laval AB (Sweden) Kelvion Holdings Gmbh (Germany) Southern Heat Exchanger (U.S.) Danfoss A/S (Denmark) SPX Corporation (U.S.) Xylem Inc. (U.S.) API Heat Transfer Inc. (U.S) Gunter AG & Co. KG (Germany) Sierra S.p.A (Italy) Hamon & Cie International SA (Belgium). , Among others.Get Free Sample...

Continue reading

Surge Protection Devices Market worth USD 5.33 billion by 2030, registering a CAGR of 5.72% – Report by Market Research Future (MRFR)

New York, Nov. 08, 2021 (GLOBE NEWSWIRE) — Surge Protection Devices Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “Surge Protection Devices Market Research Report,by Application , Type , Voltage and Region – Forecast till 2030” the market is projected to be worth USD 5.33 billion by 2030, registering a CAGR of 5.72% during the forecast period (2022 – 2030), The market was valued at USD 3.24 billion in 2021. List of the companies profiled in the global surge protection devices industry report include –Schneider Electric SE (France) ABB Ltd. (Switzerland) Mitsubishi Electric Corporation (Japan) Alstom SA (France) Siemens AG (Germany) and Toshiba (Japan). Larsen & Turbo (India) Hyundai heavy industries (South Korea) Hitachi (Japan) Fuji Electric (Japan) Nissin...

Continue reading

Share buy-back programme – week 44

Nasdaq CopenhagenLondon Stock ExchangeEuronext DublinOther stakeholders Date        08.11.2021 Share buy-back programme – week 44 The share buy-back programme runs from and including 1 October 2021 up to and including 25 January 2022. During this period Ringkjøbing Landbobank will buy-back shares to a maximum market value of DKK 30 million under a share buy-back programme, see company announcement of 15 September 2021. The programme is implemented in compliance with EU Commission Regulation No. 596/2014 of 16 April 2014 and EU Commission Delegated Regulation No. 2016/1052 of 8 March 2016, which together constitute the “Safe Harbour” regulation. The following transactions have been made under the share buy-back programme:Date Number of shares Average purchase price (DKK) Total purchased under the programme (DKK)Total in accordance...

Continue reading

DSV, 928 – SHARE BUYBACK IN DSV A/S

Company Announcement No. 928 On 26 October 2021, we initiated a share buyback programme, as described in Company Announcement No. 925. According to the programme, the company will in the period from 26 October 2021 to 8 February 2022 purchase own shares up to a maximum value of DKK 5,000 million and no more than 5,000,000 shares, corresponding to 2.08% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules.Trading day   Number of shares bought back   Average transaction price   Amount DKK               Accumulated trading for days 1-4 319,027   1,501.95   479,161,5775: 1 November 2021   46,988   1,505.52   70,741,4256: 2...

Continue reading

Multiple Sclerosis Drugs Market to Reach USD 41.99 Billion by 2028 | Market Projection By Technology, Major key players, Growth, Revenue, CAGR, Regional Analysis, Industry Forecast To 2028

Key Prominent Players Covered in the Multiple Sclerosis Drugs Market are Biogen, Pfizer Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Merck & Co., Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Other Players Pune, India, Nov. 08, 2021 (GLOBE NEWSWIRE) — The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to discover innovative and effective therapies for the treatment of this immune disorder. For instance, in December 2020, Adamas Pharmaceuticals, Inc. declared the results of its phase 3 clinical trials on ADS-5102, for the treatment of multiple sclerosis (MS) patients. This information is given by Fortune Business Insights™ in a published report, titled, “Multiple Sclerosis Drugs Market, 2021-2028.”...

Continue reading

Customer Data Platform Market to Reach USD 5,503.4 Million by 2028; Growing Adoption of Machine Learning & Artificial Intelligence to Propel Market Growth: Says Fortune Business Insights™

Companies Profiled in Customer Data Platform Market Are Salesforce.com, Inc. (U.S.), Exponea s.r.o (Slovakia), Segment.io, Inc. (U.S.), Optimove Inc. (U.S.), Oracle Inc. (U.S.), Leadspace, Inc. (U.S.), Ignitionone.com (U.S.), Kabbage Inc. (Radius Intelligence) (U.S.), Tealium Inc. (U.S.), CaliberMind (U.S.) Pune, India, Nov. 08, 2021 (GLOBE NEWSWIRE) — The global customer data platform market size is anticipated to reach USD 5,503.4 million by 2028 and exhibit a CAGR of 25.0% during the forecast period. The increasing importance of CRM and customer satisfaction is likely to be the key growth propellant for the market. Fortune Business Insights™ has presented this information in its report titled, “Customer Data Platform Market, 2021-2028”. The market size stood at USD 942.9 million in 2020.Request a Sample Copy of Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/customer-data-platform-market-100633Technological...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.